Sulfamate derivative compounds for use in treating or alleviating a psychiatric disorder

A method for treating a psychiatric disorder in a subject, comprising:

• selecting a subject having a psychiatric disorder;
• and
• administering to the subject a pharmaceutical composition comprising a sulfamate derivative compound of Chemical Formula I or a pharmaceutically acceptable salt thereof:
• wherein
• R1 and R2 are each independently selected from the group consisting of hydrogen, C1-C5 alkyl, C2-C5 alkenyl and C6-C10 aryl, R1 and R2 together with the carbon atom to which they attach form a C3-C12 cycloalkyl group, or R1 and R2 are bond and they together with the oxygen atom to which they attach form a carbonyl group;
• A is an aryl moiety or a heterocyclic moiety optionally substituted by one or more substituents selected from the group consisting of hydrogen, hydroxyl, C1-C5 alkoxy, C1-C5 alkyl, C2-C5 alkenyl, C6-C10 aryl, C1-C5 alkoxycarbonyl, carboxyl, C2-C5 acyl, C1-C5 alkylthio, cyano, nitro, amine, C1-C5 alkylamine and halogen;
• R3 and R4 are each independently hydrogen or C1-C3 alkyl;
• l and m are each independently an integer of 0˜4;
• and
• the psychiatric disorder is selected from the group consisting of anxiety disorder, mood disorder, somatoform disorder, dissociative disorder, psychotic disorder, personality disorder, sexual disorder, sexual identity disorder, substance-related disorder, eating disorder, sleep disorder, impulse control disorder and adjustment disorder.